Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1NETWORK 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 4Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Lung Neoplasms 3Colorectal Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Wilms Tumor 2Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Sarcoma, Ewing 2Sarcoma 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Head and Neck Neoplasms 2Esophageal Neoplasms 2Carcinoma, Ovarian Epithelial 2Adenocarcinoma of Lung 2Adenocarcinoma Of Esophagus 2Vaginal Neoplasms 1Urethral Neoplasms 1Testicular Neoplasms 1Teratoma 1Rhabdomyosarcoma 1Rectal Neoplasms 1Radiation Injuries 1Radiation Fibrosis Syndrome 1Prostatic Neoplasms 1Postoperative Complications 1Ovarian Germ Cell Cancer 1Osteosarcoma 1

Interventions

Cyclophosphamide 5Epirubicin 4Docetaxel 4pegfilgrastim 2Trastuzumab 2Radiotherapy 2Filgrastim 2Doxorubicin 2Bevacizumab 2Taxes 1Surgical Procedures, Operative 1Paclitaxel 1Neoadjuvant Therapy 1Microarray Analysis 1Lapatinib 1Immunohistochemistry 1Granulocyte Colony-Stimulating Factor 1Fluorouracil 1Capecitabine 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Inflammatory Breast Neoplasms × Surgical Procedures, Operative × Clear all
NCT00016406 2013-01-24

S0012 Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflammatory or Locally Advanced Breast Cancer

SWOG Cancer Research Network

Phase 3 Completed
399 enrolled
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡